Regeneron Pharmaceuticals – with the U.S. National Institute of Allergy and Infectious Diseases (NIAID) – is launching Phase III trials of REGN-COV2, the company’s two-antibody cocktail for the treatment and prevention of COVID-19.
A look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.
A review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
Cambridge, Massachusetts-based Thrive Earlier Detection released data from the DETECT-A study evaluating the company’s blood test to screen for multiple types of cancers. The study was run by Johns Hopkins University and Geisinger Health, testing more than 10,000 women with no previous history of cancer.
Social distancing has become the new norm in the attempt to prevent the spread of COVID-19, and that norm could become a mainstay of life for the next couple years, a new study suggests.
Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.
Results from NASA’s landmark Twins Study reveals some interesting, surprising and reassuring data.
Prior infection with dengue, a mosquito-borne disease that infects nearly 400 million people a year, could reduce the risk of contracting Zika nearly by half, U.S. and Brazilian researchers reported.